Cargando…
Efficient treatment of Parkinson’s disease using ultrasonography-guided rhFGF20 proteoliposomes
Fibroblast growth factor-20 (FGF20) is a paracrine member of the FGF family that is preferentially expressed in the substantia nigra pars compacta (SNpc). Previous studies have demonstrated that FGF20 enhances the survival of dopaminergic neurons suggesting the potential use of FGF20 to treat Parkin...
Autores principales: | Niu, Jianlou, Xie, Junjun, Guo, Kaiwen, Zhang, Xiaomin, Xia, Feng, Zhao, Xinyu, Song, Lintao, Zhuge, Deli, Li, Xiaokun, Zhao, Yingzheng, Huang, Zhifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060384/ https://www.ncbi.nlm.nih.gov/pubmed/30043675 http://dx.doi.org/10.1080/10717544.2018.1482972 |
Ejemplares similares
-
Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice
por: Zhao, Longwei, et al.
Publicado: (2017) -
Periodontal surgery using rhFGF‐2 with deproteinized bovine bone mineral or rhFGF‐2 alone: 2‐year follow‐up of a randomized controlled trial
por: Aoki, Hideto, et al.
Publicado: (2020) -
Treatment of intrabony periodontal defects using rhFGF‐2 in combination with deproteinized bovine bone mineral or rhFGF‐2 alone: A 6‐month randomized controlled trial
por: Saito, Atsushi, et al.
Publicado: (2019) -
A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol
por: Huang, Zhifeng, et al.
Publicado: (2011) -
FGF23(C-tail) improves diabetic nephropathy by attenuating renal fibrosis and inflammation
por: Zhang, Xiaomin, et al.
Publicado: (2018)